Trial Profile
Feasibility Study to Compare 2 Strategies of Treatment Algorithm for Treating Nausea and or Vomiting in the Palliative Phase of Cancer Care
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Granisetron (Primary) ; Granisetron (Primary) ; Metoclopramide (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 12 Jan 2017 New trial record